About Jinxin Fertility
Jinxin Fertility is a company based in Chengdu (China) founded in 2003.. Jinxin Fertility has raised $150 million across 2 funding rounds from investors including WuXi AppTec, Warburg Pincus and Orbimed. The company has 3,200 employees as of December 31, 2024. Jinxin Fertility operates in a competitive market with competitors including Amcare, Angel's Maternity Hospital, Bosheng Medical and Tibet Fukang Medical, among others.
- Headquarter Chengdu, China
- Employees 3200 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Jinxin Fertility Group Ltd.
-
Annual Revenue
$392.71 M (USD)-1.08as on Dec 31, 2024
-
Net Profit
$39.52 M (USD)-19.42as on Dec 31, 2024
-
EBITDA
$100.43 M (USD)-7.93as on Dec 31, 2024
-
Total Equity Funding
$150 M (USD)
in 2 rounds
-
Latest Funding Round
$150 M (USD), Private Equity Round
Jun 14, 2019
-
Investors
WuXi AppTec
& 7 more
-
Employee Count
3200
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Jinxin Fertility
Jinxin Fertility is a publicly listed company on the HKEX with ticker symbol 1951 in Hong Kong, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Jinxin Fertility
Jinxin Fertility has successfully raised a total of $150M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $150 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Private Equity Round — $150.0M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2019 | Amount | Private Equity Round - Jinxin Fertility | Valuation | Orbimed | |
| Oct, 2018 | Amount | Private Equity Round - Jinxin Fertility | Valuation | Warburg Pincus , CNBC |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Jinxin Fertility
Jinxin Fertility has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include WuXi AppTec, Warburg Pincus and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Global private equity investments are managed with long-term focus.
|
Founded Year | Domain | Location | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Jinxin Fertility
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Jinxin Fertility
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Jinxin Fertility Comparisons
Competitors of Jinxin Fertility
Jinxin Fertility operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amcare, Angel's Maternity Hospital, Bosheng Medical and Tibet Fukang Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Chain of women and children hospitals
|
|
| domain | founded_year | HQ Location |
Obstetrics and gynaecology services are provided through a hospital chain.
|
|
| domain | founded_year | HQ Location |
Operates a chain of obstetrics and gynaecology hospitals.
|
|
| domain | founded_year | HQ Location |
Delivers focused medical services as a dedicated healthcare provider.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Jinxin Fertility
Frequently Asked Questions about Jinxin Fertility
When was Jinxin Fertility founded?
Jinxin Fertility was founded in 2003 and raised its 1st funding round 15 years after it was founded.
Where is Jinxin Fertility located?
Jinxin Fertility is headquartered in Chengdu, China. It is registered at Chengdu, Sichuan, China.
Is Jinxin Fertility a funded company?
Jinxin Fertility is a funded company, having raised a total of $150M across 2 funding rounds to date.
How many employees does Jinxin Fertility have?
As of Dec 31, 2024, the latest employee count at Jinxin Fertility is 3,200.
What is the annual revenue of Jinxin Fertility?
Annual revenue of Jinxin Fertility is $392.71M as on Dec 31, 2024.
What does Jinxin Fertility do?
Jinxin Fertility was established in 2003 in Chengdu, China, within the healthcare sector. A network of gynaecology hospitals is managed, focusing on reproductive health and fertility treatments. Services encompass womens gynaecological care, infertility diagnostics, and assisted reproductive technologies. Operations are primarily based in China, serving regional patients through multiple facilities.
Who are the top competitors of Jinxin Fertility?
Jinxin Fertility's top competitors include Amcare, Angel's Maternity Hospital and Bosheng Medical.
Is Jinxin Fertility publicly traded?
Yes, Jinxin Fertility is publicly traded on HKEX under the ticker symbol 1951.
Who are Jinxin Fertility's investors?
Jinxin Fertility has 8 investors. Key investors include WuXi AppTec, Warburg Pincus, Orbimed, CPP Investments, and Hillhouse.
What is Jinxin Fertility's ticker symbol?
The ticker symbol of Jinxin Fertility is 1951 on HKEX.